Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice

Overview of attention for article published in Biological Psychiatry, September 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

patent: 13 patents

facebook: 1 Facebook page

Readers on

mendeley: 131 Mendeley

So far, Altmetric has seen 13 patents that reference this research output.

Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof

Grant US-12486289-B2

United States of America

02 Dec 2025

Kinase inhibitors and methods of use thereof

Grant US-12419885-B2

United States of America

23 Sep 2025

COMPOSITIONS AND TREATMENTS FOR FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER

Application WO-2025099490-A2

World Intellectual Property Organisation (WIPO)

15 May 2025

1,2-DIHYDROQUINOLINE-2-ONES FOR THEIR USE IN THE TREATMENT OF LIMB-GIRDLE MUSCULAR…

Application WO-2022248394-A1

World Intellectual Property Organisation (WIPO)

01 Dec 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 9 additional patents.